Literature DB >> 29887605

The Royal College of Ophthalmologists recommendations on screening for hydroxychloroquine and chloroquine users in the United Kingdom: executive summary.

Imran H Yusuf1, Barny Foot2, James Galloway3, Michael R Ardern-Jones4, Sarah-Lucie Watson5, Cathy Yelf6, Michael A Burdon7, Paul N Bishop8, Andrew J Lotery9.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2018        PMID： 29887605      PMCID： PMC6043500          DOI： 10.1038/s41433-018-0136-x

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN： 0950-222X            Impact factor:   3.775


× No keyword cloud information.
  6 in total

1.  Hydroxychloroquine use: the potential impact of new ocular screening guidelines.

Authors:  M Yates; R Malaiya; J Stack; J B Galloway
Journal:  Eye (Lond)       Date:  2017-08-11       Impact factor: 3.775

2.  Hydroxychloroquine retinopathy: an emerging problem.

Authors:  M Latasiewicz; H Gourier; I H Yusuf; R Luqmani; S M Sharma; S M Downes
Journal:  Eye (Lond)       Date:  2017-02-10       Impact factor: 3.775

3.  The risk of toxic retinopathy in patients on long-term hydroxychloroquine therapy.

Authors:  Ronald B Melles; Michael F Marmor
Journal:  JAMA Ophthalmol       Date:  2014-12       Impact factor: 7.389

4.  Effect of hydroxychloroquine on the survival of patients with systemic lupus erythematosus: data from LUMINA, a multiethnic US cohort (LUMINA L).

Authors:  Graciela S Alarcón; Gerald McGwin; Ana M Bertoli; Barri J Fessler; Jaime Calvo-Alén; Holly M Bastian; Luis M Vilá; John D Reveille
Journal:  Ann Rheum Dis       Date:  2007-03-27       Impact factor: 19.103

5.  The incidence of irreversible retinal toxicity in patients treated with hydroxychloroquine: a reappraisal.

Authors:  Ioannis Mavrikakis; Petros P Sfikakis; Emmanouil Mavrikakis; Kostantinos Rougas; Athanasios Nikolaou; Charalambos Kostopoulos; Myron Mavrikakis
Journal:  Ophthalmology       Date:  2003-07       Impact factor: 12.079

Review 6.  Hydroxychloroquine retinopathy.

Authors:  I H Yusuf; S Sharma; R Luqmani; S M Downes
Journal:  Eye (Lond)       Date:  2017-03-10       Impact factor: 3.775
  6 in total
  12 in total

Review 1.  [State of the art: systemic lupus erythematosus].

Authors:  J Mucke; R Fischer-Betz; M Schneider
Journal:  Z Rheumatol       Date:  2019-08       Impact factor: 1.372

2.  MERCI: a machine learning approach to identifying hydroxychloroquine retinopathy using mfERG.

Authors:  Faisal Habib; Huaxiong Huang; Arvind Gupta; Tom Wright
Journal:  Doc Ophthalmol       Date:  2022-06-22       Impact factor: 1.854

Review 3.  An overview of the safety assessment of medicines currently used in the COVID-19 disease treatment.

Authors:  Dragana Javorac; Lazar Grahovac; Luka Manić; Nikola Stojilković; Milena Anđelković; Zorica Bulat; Danijela Đukić-Ćosić; Marijana Curcic; Aleksandra Buha Djordjevic
Journal:  Food Chem Toxicol       Date:  2020-07-21       Impact factor: 6.023

Review 4.  Hydroxychloroquine and chloroquine retinal safety concerns during COVID-19 outbreak.

Authors:  Massimo Nicolò; Lorenzo Ferro Desideri; Matteo Bassetti; Carlo Enrico Traverso
Journal:  Int Ophthalmol       Date:  2020-09-18       Impact factor: 2.031

Review 5.  Recommendations for eye care during the alarm state by the coronavirus disease pandemic COVID-19.

Authors:  J A Gegúndez-Fernández; J Zarranz-Ventura; G Garay-Aramburu; F J Muñoz-Negrete; J Mendicute Del Barrio; L Pablo-Júlvez; S García-Delpech; A López-Alemany; F Arnalich-Montiel; M Cordero-Coma; J A Cárceles
Journal:  Arch Soc Esp Oftalmol (Engl Ed)       Date:  2020-04-25

6.  Hydroxychloroquine treatment in European patients with lupus erythematosus: dosing, retinopathy screening and adherence.

Authors:  Zgjim Osmani; Thijs J Schrama; Wendy Zacouris-Verweij; Jeanette Andersen; Susan Frankel; Irene E M Bultink; Alain Cornet; Ronald F van Vollenhoven
Journal:  Lupus Sci Med       Date:  2021-03

7.  Frequency and risk factors for hydroxychloroquine retinopathy among patients with systemic lupus erythematosus.

Authors:  Mohammed Salah Eldin Abdelbaky; Tarek Ahmad El Mamoun; Fatma Ibrahim Mabrouk; Rasha Mohamad Hassan
Journal:  Egypt J Intern Med       Date:  2021-06-08

8.  Prevalence of hydroxychloroquine retinopathy using 2018 Royal College of Ophthalmologists diagnostic criteria.

Authors:  Elena Marshall; Matt Robertson; Satu Kam; Alison Penwarden; Paraskevi Riga; Nigel Davies
Journal:  Eye (Lond)       Date:  2020-06-25       Impact factor: 4.456

9.  Hydroxychloroquine hitting the headlines-retinal considerations.

Authors:  Susan M Downes; Bart P Leroy; Srilakshmi M Sharma; Sobha Sivaprasad; Hélène Dollfus
Journal:  Eye (Lond)       Date:  2020-05-19       Impact factor: 4.456

Review 10.  Immunomodulatory Effects of Hydroxychloroquine and Chloroquine in Viral Infections and Their Potential Application in Retinal Gene Therapy.

Authors:  Laurel C Chandler; Imran H Yusuf; Michelle E McClements; Alun R Barnard; Robert E MacLaren; Kanmin Xue
Journal:  Int J Mol Sci       Date:  2020-07-14       Impact factor: 5.923
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.